Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Physical Chemistry. A|July 4, 2023
Exploring the Chemical Dynamics of Phenylethynyl Radical (C6H5CC; X2A1) Reactions with Allene (H2CCCH2; X1A1) and Methylacetylene (CH3CCH; X1A1)Shane J Goettl, Zhenghai Yang, Siegfried Kollotzek, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|February 19, 2016
SURGERY OF CONGENITAL MALFORMATIONS IN NEWBORNSV A Savvina, A R Varfolomeyev, V N Nikolayev, et al.
CNS & Neurological Disorders Drug Targets|March 16, 2017
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in MiceAnna E Martin, Douglas A Schober, Alexander Nikolayev, et al.
Biomedicines|August 26, 2023
Immunomorphogenesis in Degenerative Disc Disease: The Role of Proinflammatory Cytokines and Angiogenesis FactorsNatalya G Pravdyuk, Anna V Novikova, Nadezhda A Shostak, et al.
Nature Communications|July 19, 2023
Implant-to-implant wireless networking with metamaterial textilesXi Tian, Qihang Zeng, Selman A Kurt, et al.
Journal of the American Chemical Society|April 17, 2024
Methanetriol─Formation of an Impossible MoleculeJoshua H Marks, Xilin Bai, Anatoliy A Nikolayev, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2014
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamineJ M Witkin, C Overshiner, X Li, et al.
International Journal of Food Science|October 11, 2021
Eurotium Cristatum Postfermentation of Fireweed and Apple Tree Leaf Herbal TeasTatiana A Efimenko, Elena F Shanenko, Tatiana G Mukhamedzhanova, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2017
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of DepressionJ M Witkin, S N Mitchell, K A Wafford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer ImmunotherapyDavid A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Pageof 11